← Back to directory

Roberto Ferrari

Researcher Next ID · RN-021447

Researcher · Medicine

University of Parma

Parma, Spain

Not currently recruitingFunding unknown
Works count
1,320
Citation count
67,457
H-index
102
i10-index
590

Research interests

Medicine
Cardiac Imaging and Diagnostics
Cardiac Ischemia and Reperfusion
Cardiovascular Function and Risk Factors
Heart Failure Treatment and Management
Cardiac electrophysiology and arrhythmias

Publications

  • Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

    New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2314328

  • Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

    European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab342

  • Patient Profiling in Heart Failure for Tailoring Medical Therapy. A Consensus Document of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2206

  • Effects of Serelaxin in Patients with Acute Heart Failure

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1801291

  • Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC Heart Failure · 2018 · https://doi.org/10.1016/j.jchf.2018.02.001

  • Epidemiology and One-Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid-Range and Reduced Ejection Fraction: An Analysis of The ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure · 2017 · https://doi.org/10.1002/ejhf.813

  • Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure · 2017 · 10.1002/ejhf.890

  • Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis

    BMC Medicine · 2016 · https://doi.org/10.1186/s12916-016-0763-7

  • European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

    European Journal of Heart Failure · 2016 · https://doi.org/10.1002/ejhf.566

  • 2014 ESC/EACTS Guidelines on myocardial revascularization

    European Journal of Cardio-Thoracic Surgery · 2014 · 10.1093/ejcts/ezu366

  • 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases

    European Heart Journal · 2014 · 10.1093/eurheartj/ehu281

  • The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu001

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

    Revista Española de Cardiología (English Edition) · 2014 · https://doi.org/10.1016/j.rec.2013.10.013

  • 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu282

  • 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

    European Heart Journal · 2014 · 10.1093/eurheartj/ehu283

  • 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

    EP Europace · 2013 · 10.1093/europace/eut206

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    European Heart Journal · 2013 · 10.1093/eurheartj/eht108

  • Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

    The Lancet · 2008 · 10.1016/s0140-6736(08)61171-x

  • Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

    The Lancet · 2008 · 10.1016/s0140-6736(08)61170-8

  • Resting Heart Rate in Cardiovascular Disease

    Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2007.04.079

  • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure

    European Heart Journal · 2005 · 10.1093/eurheartj/ehi044

  • Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction

    JAMA · 2005 · https://doi.org/10.1001/jama.293.17.2109

  • Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

    European Heart Journal · 2005 · 10.1093/eurheartj/ehi115

Current projects

    No projects listed.